Public Health Assessment: Highway 36 Corridor Exposure Investigation
Total Page:16
File Type:pdf, Size:1020Kb
Final Public Health Assessment Highway 36 Corridor Exposure Investigation October 2014 Prepared by the Environmental Health Assessment Program Oregon Health Authority; Public Health Division i Funded under a cooperative agreement with the Agency for Toxic Substances and Disease Registry. (Grant no. 280603) ii Oregon Health Authority - Highway 36 Public Health Assessment October 2014 Foreword The Oregon Health Authority (OHA), in cooperation with state and federal partners, prepared this Public Health Assessment (PHA). The Agency for Toxic Substances and Disease Registry (ATSDR) and its Oregon cooperative agreement partner, the Environmental Health Assessment Program (EHAP), conduct public health assessments to evaluate environmental data and community concerns. Contained within this PHA are the results of the Highway 36 Corridor Exposure Investigation (EI). The EI was conducted in response to resident’s concerns about potential exposures from pesticide applications occurring on forestlands near their homes and schools. At an April 2011 Board of Forestry meeting, several residents announced the results of a community- led, urine sampling effort. The results showed elevated levels of atrazine and 2,4-D in their urine. The Oregon Department of Forestry (ODF) notified the Pesticide Analytic and Response Center (PARC) of the results. As co-chair of PARC, OHA joined a multi-agency workgroup to develop the Highway 36 Corridor Exposure Investigation (EI) in order to determine if people are being exposed to pesticides in the Highway 36 corridor, and if so, the health implications of these exposures. For the purposes of this document, the following definitions apply: Public Health Assessment (PHA): A PHA is an evaluation tool of choice when a site contains multiple contaminants and multiple, potential pathways of exposure. PHAs are conducted in an effort to determine whether a community is being exposed to environmental contaminants at levels that could harm human health. PHAs are not the same as medical exams, community health studies1, or epidemiological studies2. A PHA is focused on a specific site or community and its findings are not intended to be generalizable to other sites or communities. Sometimes critical data needed for a PHA are missing or not available. In such cases, ATSDR may conduct an Exposure Investigation (EI). Exposure Investigation (EI): An EI is one approach used to better characterize past, current and possible future human exposures and to evaluate both existing and possible exposure-related health effects. An EI involves the collection and analysis of environmental data and, when appropriate, biologic data (such as urine or blood). The goal of an EI is to determine whether people have been, or are being, exposed to hazardous substances. An EI is one of several possible approaches to characterize past, current and possible future human exposures to environmental contaminants. An EI is not an epidemiological study or experiment. As such, some components of other types of studies, such as control groups, are not included in an EI. 1 A community health study (CHS) requires careful methods of measuring exposure and illness. Diseases can be caused by many different factors. It may be difficult to determine if a disease is caused by exposure to contaminants and not due to these other factors. A CHS presents many challenges and they are rarely conducted in small communities. 2 Epidemiology (epi) is the study of the incidence, distribution and determinants of disease. Various methods can be used to carry out epi investigations, including descriptive studies used to study distribution and analytical studies to study determinants. The four most common types of epidemiological studies are 1) a cohort study, 2) a case-control study, 3) an occupational epi study, and 4) a cross-sectional study. iii Oregon Health Authority - Highway 36 Public Health Assessment October 2014 This PHA reports on the results of the Highway 36 Corridor EI to date. It contains an analysis of information and data (qualitative, biologic and environmental) collected between April 2011 and September 2012. The EI findings are nested within the broader public health assessment process that ATSDR uses. Therefore, it is important to note that this PHA is the tool used to communicate the EI findings. OHA serves as the lead agency for coordinating and implementing this investigation. Three other state agencies (which are members of PARC), and two federal agencies are involved in this effort. These agencies are: • Oregon Department of Agriculture (ODA); Administrator of PARC • Oregon Department of Forestry (ODF); PARC Member Agency • Oregon Department of Environmental Quality (DEQ); PARC Member Agency • Centers for Disease Control and Prevention (CDC) • Agency for Toxic Substances and Disease Registry (ATSDR) headquarters (Atlanta, GA) and Region 10 office (Seattle, WA) • National Center for Environmental Health (NCEH) laboratory (Atlanta, GA) • U.S. Environmental Protection Agency (EPA) o EPA Region 10 (Seattle, WA) o EPA Office of Pesticides Programs (Washington, DC) • PARC consultants from the Oregon Health and Science University (OHSU) and Oregon State University (OSU) also provide technical assistance and consultation for this investigation. This group of agencies has provided input into the EI according to their areas of expertise and legal authority. For example, DEQ and EPA were responsible for collecting environmental data, and were key partners when writing pieces of the report related to the environmental samples. Each agency has reviewed the report and provided input, feedback and edits to the sections relevant to their agency. In addition, the group as a whole met several times to discuss issues as they arose and arrived at agreement on how to report the EI results. Funding and other staff resources used to conduct this EI was contributed by all state and federal agencies involved. OHA Public Health Division (OHA/PHD) houses the Environmental Health Assessment Program (EHAP), which is the ATSDR-cooperative agreement program funded to carry out ATSDR’s work in Oregon. EHAP staff are the primary authors of this report. iv Oregon Health Authority - Highway 36 Public Health Assessment October 2014 Purpose and Statement of Issues This PHA reports on the available information and data collected to date for the Highway 36 Corridor EI. The Highway 36 Corridor is located in western Lane County, Oregon. The EI is a multi-agency response to several community members’ requests to investigate possible exposures to pesticides and herbicides used in industrial forestland applications near their residences and schools. The purpose of the EI is to fill important data gaps by collecting and analyzing available information and environmental, biologic and qualitative data to answer the following questions: 1. Are residents in the Highway 36 Corridor being exposed to pesticides from local application practices? 2. If residents are being exposed: a. To what pesticides are they being exposed? b. To what levels are they being exposed? c. What are potential source(s) of the pesticides to which they are exposed? d. What are potential routes (pathways) of residents’ exposures? e. What health risks are associated with these exposures? As described in the “Background” and “Community Concerns” sections of this report, several Highway 36 Corridor residents are concerned about how these herbicide applications may be affecting their health. Therefore, this EI focuses on collecting and evaluating data on herbicides that are used in this area. Because “pesticide” is a more inclusive and commonly understood term, we use “pesticide” from this point forward to refer to herbicides, insecticides, fungicides, rodenticides and similar products regulated under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). v Oregon Health Authority - Highway 36 Public Health Assessment October 2014 Table of Contents Foreword .................................................................................................................................................... iii Purpose and Statement of Issues ................................................................................................................. v List of Abbreviations and Acronyms ....................................................................................................... viii Summary ..................................................................................................................................................... 1 Background ............................................................................................................................................... 12 Investigation Area ................................................................................................................................. 12 Recruitment Area .................................................................................................................................. 12 Site Description ..................................................................................................................................... 12 Investigation History ............................................................................................................................. 13 Discussion ................................................................................................................................................. 15 Exposure Pathway Analysis .................................................................................................................